Reported Consolidated quarterly numbers for Nile are: Net Sales at Rs 251.68 crore in September 2024 up 0.39% from Rs. 250.71 crore in September 2023. Quarterly Net Profit at Rs. 8.37 crore in September 2024 up 2.39% from Rs. 8.18 crore in September 2023. EBITDA stands at Rs. 12.65 crore in September 2024 up 4.81% from Rs. 12.07 crore in September 2023.
Open FlipReported Consolidated quarterly numbers for Innova Captab are: Net Sales at Rs 318.20 crore in September 2024 up 12.46% from Rs. 282.94 crore in September 2023. Quarterly Net Profit at Rs. 35.00 crore in September 2024 up 52.82% from Rs. 22.91 crore in September 2023. EBITDA stands at Rs. 51.95 crore in September 2024 up 18.55% from Rs. 43.82 crore in September 2023.
Open FlipMultibagger Stock: The Board of Directors of Sudarshan Pharma Industries, in a meeting held on Thursday, set November 18 (Monday) as the record date for its proposed stock split. On October 1, the board approved the sub-division of equity shares in a 1:10 ratio. The company’s shares have experienced a significant upward trend over the past six months, including November.
Open Flip